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Maintaining stem cell quiescence is intimately connected to preserving long-term self-renewal potential. In
this issue of Cell Stem Cell, Paik et al. (2009) and Renault et al. (2009) demonstrate a role for FoxO transcrip-
tion factors in regulating neural stem cell proliferation and in maintaining stem and progenitor cell homeo-
stasis.Most of us remember the childhood tale
‘‘The Tortoise and the Hare,’’ in which
the hare begins a race with a burst of
energy and enthusiasm to take an early
and seemingly insurmountable lead, but
winds up losing to the tortoise in the
end. In the current issue of Cell Stem
Cell, two groups show that the lessons
of Aesop’s fable may be equally applied
to the biology of the neural stem cell
(NSC). Together, these two manuscripts
demonstrate that the FoxO family of tran-
scription factors exerts an important
constraint on NSC proliferation (Paik
et al., 2009; Renault et al., 2009). Like
the proverbial hare, FoxO-deficient NSCs
initially seem robust and invincible. Yet
this initial burst of postnatal activity
quickly disappears and as the mice age,
FoxO-deficient stem cells appear to
rapidly decrease in both number and
function. In contrast, wild-type mice—
although slower out of the gate—appear
to better preserve their stem cell function
throughout adulthood. As such, it would
seem that in both childhood tales and
stem cell biology, slow and steady wins
the race.
In mammals, the FoxO family of tran-
scription factors consists of four mem-
bers: FoxO1, FoxO3, FoxO4, and FoxO6.
Activation of the PI3K/Akt pathway after
insulin or growth factor stimulation results
in FoxO phosphorylation and inactivation
due to retention in the cytoplasm. In con-
trast, certain stresses, such as oxidative
or nutrient stress, result in FoxO nuclear
accumulation. Once in the nucleus, FoxO
proteins transactivate a large array of
downstream targets including cell-cycle
inhibitors, metabolic regulators, and
genes involved in stress resistance. The
precise targets appear to vary depending
on both what kind of stress is involved andthe specific tissue being studied (Salih
and Brunet, 2008). In contrast to mam-
mals, worms and flies express only one
FoxO member. In C. elegans, the single
FoxO isoform is denoted as DAF-16,
whereas in flies, it is known as dFOXO.
Interestingly, the general transcriptional
targets of DAF-16 include both metabolic
and stress resistance genes that in many
cases are similar to those regulated by
mammalian FoxO factors. Even more
intriguing, increased expression of DAF-
16 in worms or dFOXO in flies results in
lifespan extension in these model organ-
isms.
Currently, the function of mammalian
FoxO factors in lifespan regulation is
unknown, although mounting evidence
suggests a role for these factors in the
maintenance of certain long-lived cell
types such as endothelium and thymo-
cytes (Paik et al., 2007). In contrast to
the postmitotic worm, most mammalian
tissues require the constant contribution
of stem and progenitor cells to maintain
tissue homeostasis. As such, it would
seem possible that genes implicated in
regulating organismal lifespan in lower
organisms might have evolved to play
a role in stem cell homeostasis. In these
two new reports, the Brunet and DePinho
lab demonstrate the plausibility of this
hypothesis by implicating mammalian
FoxO activity in the regulation of NSC
proliferation and self-renewal. The two
manuscripts use two slightly different
models, with one group studying a
whole body or conditional knockout of
FoxO3/, and the other group employing
a brain-specific conditional triple knock-
out of FoxO1/3/4. Both groups find that
reducing FoxO activity leads to an
in vivo increase in NSC/progenitor prolif-
eration immediately after birth. Indeed,Cell Stem Cell 5both animal models resulted in a larger
overall brain size presumably due to this
enhanced proliferation. However, long-
term BrdU labeling or staining with Ki67
reveals that as the mice age, pro-
liferation within the stem and progen-
itor compartment falls off precipitously.
Complementary in vitro experimentation
demonstrates an age-dependent decline
in primary and secondary neurosphere
formation, consistent with a decline in
the number and self-renewal capacity
of NSCs that lack FoxO activity. Thus,
FoxO activity within the NSC compart-
ment appears to be required to maintain
stem cell quiescence. In the absence of
FoxO activity, the early expansion of
progenitors cannot be sustained, and as
the animals matures, the number and
activity of the NSC pool declines rapidly.
These results are not the first to demon-
strate a role for FoxO proteins in maintain-
ing stem cell homeostasis. A previous
analysis of the FoxO3/ mouse as well
as examination of a conditional triple
FoxO1/3/4 knockout within hematopoi-
etic stem cells (HSCs) revealed that the
HSC compartment is also regulated by
FoxO activity (Miyamoto et al., 2007;
Tothova et al., 2007). In both of these
models, reduced FoxO activity was asso-
ciated with a rise in reactive oxygen
species (ROS) levels within HSCs and
a subsequent defect in quiescence, a
decrease in self-renewal, and a depletion
of stem cell number. The rise in ROS
levels within HSCs appears to relate to
the known role of FoxO proteins in regu-
lating the transcription of various antioxi-
dant gene products such as superoxide
dismutase and catalase (Kops et al.,
2002; Nemoto and Finkel, 2002). These
results suggest that alterations in various
critical tissue-specific transcriptional, November 6, 2009 ª2009 Elsevier Inc. 451
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Figure 1. A Conserved Role for FoxO Family Members
In C. elegans, a single FoxO family member DAF-16 regulates lifespan by altering the expression of
numerous transcriptional targets, many of which are involved in cellular metabolism and augmenting
stress resistance. In contrast to the postmitotic worm, FoxO transcription factors in mammals have four
family members and their role appears to have expanded to include regulation of neural and hematopoietic
stem cell proliferation and self-renewal.targets might also underlie the defects
seen in NSCs. In this regard, the two
manuscripts implicate a number of poten-
tial candidates. Both models suggest a
defect in the expression of genes involved
in cell-cycle arrest and oxidative stress
resistance. In addition, FoxO targets
within the NSCs appear to include genes
involved in the response to hypoxia,
glucose metabolism, the Wnt signaling
pathway, and to a particular gene,
ASPM1, previously linked to symmetric
cell division and to cortical size in humans
(see Figure 1).
Although these studies definitively
implicate the FoxO family of transcription
factors in maintaining neural stem and
progenitor cell homeostasis, caveats and
questions remain. First, the caveat: in
contrast to HSCs for which self-renewal
assays can involve the transplantation
of single immunopurified cells to an
irradiated host, followed by large-scale
cellular expansion, the assay for NSC
self-renewal relies instead on a tissue-
culture-based assay known as secondary
neurosphere formation. Questions persist
regarding the physiological relevance of
this in vitro assay and whether it truly452 Cell Stem Cell 5, November 6, 2009 ª20measures the self-renewal capacity of
a stem cell as opposed to the activity of
an immature progenitor (Reynolds and
Rietze, 2005). Assay aside, these new
studies do seemingly highlight the tight
relationship between preserving quies-
cence and the age-dependent mainte-
nance of overall stem and progenitor
cell function. Previous studies analyzing
mice deficient for the cell-cycle regulator
p21 have also demonstrated an increase
in early proliferation of NSCs followed by
an accelerated age-dependent loss of
NSC self-renewal capacity (Kippin et al.,
2005). In contrast, NSCs lacking the
phosphatase PTEN appear to demon-
strate augmented proliferation without
an apparent decrease in stem cell mainte-
nance (Gregorian et al., 2009). The basis
for such differences remains obscure.
Perhaps within the NSC, PTEN can
simultaneously regulate the activity of
multiple pathways including both FoxO
and mTOR that are linked to maintaining
‘‘stemness.’’ Perhaps this capacity to
induce an increase in proliferation without
an apparent corresponding decrease in
self-renewal is also why mutations in
PTEN are so commonly found in deadly09 Elsevier Inc.brain tumors such as glioblastomas.
Further understanding of the connection
between quiescence and stem cell main-
tenance promises to provide important
insights into the intersection of stem cell
biology with both aging and cancer.
Indeed, it is likely that the molecular regu-
lators of quiescence and self-renewal will
continue to be heavily enriched for genes
previously implicated in either tumor
formation or lifespan regulation. Signifi-
cant gaps remain, including the develop-
ment of an integrative picture that incor-
porates how within the context of the
niche, extracellular cues from molecules
such as Wnt are potentially coupled to
intracellular parameters such as glucose
metabolism to ultimately regulate the
balance between stem cell growth and
quiescence. As Aesop would say, let the
race begin!
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